5LIN M, SUPERKO R, WILLIAMS P, et al. The atherogenic lipid profile is associated with type 2 diabetes and some of its treatment modalities [ J]. Diabetes Nutr Metab, 2003, 16 (1) : 56-64.
6WENG J. Induction of long-term glycaemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function [ J ] . Diabetes Care, 2004, 27 ( 11 ) : 2597-2602.
7DOBIASOVA M, FROHLICH J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER (HDL) ) [J]. Clin Biochem, 2001, 34 (7):583-588.
8DOBIASOVA M. Atherogenic index of plasma [ log ( triglycerides/HDL-cholesterol ) ] : theoretical and practical implications [J]. Clin Chem, 2004, 50 (7) : 1113-1115.
9WENG J, LI Y, XU W, et al. Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial [J]. Lancet, 2008, 71 (9626): 1753-1760.
10LAAKSO M, LEHTO S, PENTTILA I, et al. Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin dependent diabetes[J].Circulation, 1993, 88 (4 Pt 1): 1421-1430.
